Displaying 1 - 2 of 2
| Active Ingredient | CYCLOSPORIN |
| Therapeutic Class | ANTINEOPLASTICS |
| Indications | Prophylaxis of graft rejection in Organ and tissue transplantation. |
| Caution | Abdominal pain; anorexia; diarrhoea; fatigue; gingival hyperplasia; headache; hepatic dysfunction. Renal dysfunction (renal structural changes on long-term administration). |
| Dose Range |
Ciclosp orin is 10 to 15 mg/kg daily , beginning 4 to 12 hours before transp lantation, and continued for 1 to 2 weeks. maintenance 2-6 mg/kg daily, reduce dose gradually to maintenance |
| Drug Interactions | |
| Pregnancy | Cyclosporin crosses the placenta; manufacturer advises to avoid unless potential More ... |
| Breast Feeding | Avoid breastfeeding during cyclosporin therapy. |
| Active Ingredient | CYCLOSPORIN |
| Therapeutic Class | EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |